190 related articles for article (PubMed ID: 15006398)
1. Synthesis and in vitro antimycobacterial activity of novel 3-(1H-pyrrol-1-yl)-2-oxazolidinone analogues of PNU-100480.
Sbardella G; Mai A; Artico M; Loddo R; Setzu MG; La Colla P
Bioorg Med Chem Lett; 2004 Mar; 14(6):1537-41. PubMed ID: 15006398
[TBL] [Abstract][Full Text] [Related]
2. Identification of a novel oxazolidinone (U-100480) with potent antimycobacterial activity.
Barbachyn MR; Hutchinson DK; Brickner SJ; Cynamon MH; Kilburn JO; Klemens SP; Glickman SE; Grega KC; Hendges SK; Toops DS; Ford CW; Zurenko GE
J Med Chem; 1996 Feb; 39(3):680-5. PubMed ID: 8576910
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of Mycobacterium tuberculosis, Mycobacterium bovis, and Mycobacterium avium by novel dideoxy nucleosides.
Rai D; Johar M; Srivastav NC; Manning T; Agrawal B; Kunimoto DY; Kumar R
J Med Chem; 2007 Sep; 50(19):4766-74. PubMed ID: 17696514
[TBL] [Abstract][Full Text] [Related]
4. Antimycobacterial activity of new quinoxaline-2-carbonitrile and quinoxaline-2-carbonitrile 1,4-di-N-oxide derivatives.
Ortega MA; Montoya ME; Jaso A; Zarranz B; Tirapu I; Aldana I; Monge A
Pharmazie; 2001 Mar; 56(3):205-7. PubMed ID: 11265583
[TBL] [Abstract][Full Text] [Related]
5. Growth inhibition of Mycobacterium bovis, Mycobacterium tuberculosis and Mycobacterium avium in vitro: effect of 1-beta-D-2'-arabinofuranosyl and 1-(2'-deoxy-2'-fluoro-beta-D-2'-ribofuranosyl) pyrimidine nucleoside analogs.
Johar M; Manning T; Tse C; Desroches N; Agrawal B; Kunimoto DY; Kumar R
J Med Chem; 2007 Jul; 50(15):3696-705. PubMed ID: 17602465
[TBL] [Abstract][Full Text] [Related]
6. 2-aryl-3-(1H-azol-1-yl)-1H-indole derivatives: a new class of antimycobacterial compounds - conventional heating in comparison with MW-assisted synthesis.
Zampieri D; Mamolo MG; Laurini E; Scialino G; Banfi E; Vio L
Arch Pharm (Weinheim); 2009 Dec; 342(12):716-22. PubMed ID: 19921681
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of 1-[3-(4-benzotriazol-1/2-yl-3-fluoro-phenyl)-2-oxo-oxazolidin-5-ylmethyl]-3-substituted-thiourea derivatives as antituberculosis agents.
Dixit PP; Patil VJ; Nair PS; Jain S; Sinha N; Arora SK
Eur J Med Chem; 2006 Mar; 41(3):423-8. PubMed ID: 16494970
[TBL] [Abstract][Full Text] [Related]
8. [New active drugs against the tuberculosis bacillus and other mycobacteria].
de Kantor IN
Medicina (B Aires); 1986; 46(1):107-12. PubMed ID: 3100907
[No Abstract] [Full Text] [Related]
9. Synthesis of novel oxazolidinone antimicrobial agents.
Ebner DC; Culhane JC; Winkelman TN; Haustein MD; Ditty JL; Ippoliti JT
Bioorg Med Chem; 2008 Mar; 16(5):2651-6. PubMed ID: 18077175
[TBL] [Abstract][Full Text] [Related]
10. New agents with antimycobacterial activity.
Marco-Contelles J; Gómez-Sánchez E
Arch Pharm (Weinheim); 2005 Nov; 338(11):562-3. PubMed ID: 16281303
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and structure-activity relationship studies of highly potent novel oxazolidinone antibacterials.
Komine T; Kojima A; Asahina Y; Saito T; Takano H; Shibue T; Fukuda Y
J Med Chem; 2008 Oct; 51(20):6558-62. PubMed ID: 18826297
[TBL] [Abstract][Full Text] [Related]
12. [In-vitro activity of two hybrid synthetic peptides having antimicrobial activity against mycobacteria].
Zerbini E; Andreu D; Tonarelli G; Sequeira MD
Rev Argent Microbiol; 2006; 38(4):221-3. PubMed ID: 17370578
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and antibacterial activities of novel oxazolidinones having cyclic sulfonamide moieties.
Kim SJ; Jung MH; Yoo KH; Cho JH; Oh CH
Bioorg Med Chem Lett; 2008 Nov; 18(21):5815-8. PubMed ID: 18842403
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and antibacterial activity of some aryloxy/thioaryloxy oxazolidinone derivatives.
Arora V; Salunkhe MM; Sinha N; Sinha RK; Jain S
Bioorg Med Chem Lett; 2004 Sep; 14(18):4647-50. PubMed ID: 15324881
[TBL] [Abstract][Full Text] [Related]
15. Antifungal and antimycobacterial activity of 1-(3,5-diaryl-4,5-dihydro-1H-pyrazol-4-yl)-1H-imidazole derivatives.
Zampieri D; Mamolo MG; Laurini E; Scialino G; Banfi E; Vio L
Bioorg Med Chem; 2008 Apr; 16(8):4516-22. PubMed ID: 18321714
[TBL] [Abstract][Full Text] [Related]
16. [Comparison of in vitro antimycobacterial activities of ansamycin and rifampicin].
Tsukamura M; Mizuno S; Toyama H; Ichiyama S
Kekkaku; 1986 Oct; 61(10):497-503. PubMed ID: 3100853
[No Abstract] [Full Text] [Related]
17. Design, synthesis and docking studies of quinoline-oxazolidinone hybrid molecules and their antitubercular properties.
Thomas KD; Adhikari AV; Chowdhury IH; Sandeep T; Mahmood R; Bhattacharya B; Sumesh E
Eur J Med Chem; 2011 Oct; 46(10):4834-45. PubMed ID: 21880400
[TBL] [Abstract][Full Text] [Related]
18. [Synthesis and antibacterial activities of 7-{4-[2-[2-substituted-4-((5S)-5-acetylaminomethyl-2-oxo-oxazolidin-3-yl)}-phenyl] -ethyl]-piperazin-1-yl}-fluoroquinolones].
Yu HJ; Zhou WC
Yao Xue Xue Bao; 2006 Oct; 41(10):990-9. PubMed ID: 17184119
[TBL] [Abstract][Full Text] [Related]
19. Activity of capuramycin analogues against Mycobacterium tuberculosis, Mycobacterium avium and Mycobacterium intracellulare in vitro and in vivo.
Koga T; Fukuoka T; Doi N; Harasaki T; Inoue H; Hotoda H; Kakuta M; Muramatsu Y; Yamamura N; Hoshi M; Hirota T
J Antimicrob Chemother; 2004 Oct; 54(4):755-60. PubMed ID: 15347635
[TBL] [Abstract][Full Text] [Related]
20. The synthesis and antimicrobial evaluation of a new series of isoxazolinyl oxazolidinones.
Weidner-Wells MA; Werblood HM; Goldschmidt R; Bush K; Foleno BD; Hilliard JJ; Melton J; Wira E; Macielag MJ
Bioorg Med Chem Lett; 2004 Jun; 14(12):3069-72. PubMed ID: 15149646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
